Endothelium derived nitric oxide is an important regulator of cardiovascular homeostasis. In the past grant cycle, we have shown the importance of Akt1 in regulating the extent of peripheral and coronary atherosclerosis in a unique murine model leading to spontaneous myocardial infarction and sudden death. In vitro studies support the importance of Akt1 as a key survival pathway in all cell types relevant to atherogenesis including endothelium (EC), smooth muscle cells (VSM) and macrophages and in vivo bone marrow transfer experiments suggested the coronary atherosclerosis in the ApoE-/-/Akt1-/- mice was of vascular origin. In the second area, we have dissected the role of the Akt1-eNOS axis as an example of specific kinase-substrate relationship promoting arteriogenesis and angiogenesis, in vivo. We have generated conditional Akt1-/- knockout mice and propose to delete this kinase from EC or VSM lineages and to examine the importance of Akt1 in each cell type during the development of atherosclerosis as well as in models of post-natal angiogenesis. In addition, we show that eNOS is required for VEGF induced changes in EC barrier function and that eNOS derived NO is a critical downstream pathway integrating VEGF signaling to VE- cadherin (VE-cad) function. Mechanistically, we will test the idea that Akt1 dependent phosphorylation of eNOS leads to NO dependent changes in paracellular permeability and vascular leakage, a critical component of the angiogenic response. We hypothesize that the Akt1 dependent phosphorylation of eNOS governs the production of NO to regulate macrovascular (atheroprotection) and microvascular (angiogenesis and permeability) functions in the cardiovascular system. As a corollary to this hypothesis, we predict that modulating eNOS phosphorylation will delay atherosclerosis and preserve regional blood flow and angiogenesis. To test these hypotheses, we will: 1.dissect the role of Akt1 regulating macrovascular (atherogenesis) and microvascular (angiogenesis) function by conditional deletion of Akt1 in vascular cells;2. decipher the importance of eNOS phosphorylation on S1176 using knockin mice expressing either constitutively active (S1176D eNOS) or less active eNOS (S1176A eNOS) and characterize the specific role of Akt1- dependent eNOS phosphorylation on S1176 in regulating atherogenesis;and 3. elucidate the mechanisms whereby eNOS-derived NO regulates endothelial cell barrier functions, specifically focusing on how NO modulates VE-cad mediated changes in junctional permeability. Collectively, this work will facilitate our understanding of the importance of eNOS phosphorylation in atherogenesis and angiogenesis and provide insights into the molecular machinery required for eNOS regulation using a multi-disciplinary approach and state-of-the-art genetic mouse models.

Public Health Relevance

This research is relevant to public health since endothelial dysfunction is a common manifestation of most cardiovascular diseases. Our research has discovered the major mechanisms of how the endothelium control blood flow and atherogenesis. Research supported by this grant may help identify new drugs that reduce heart disease and improve the quality of life of people suffering with cardiovascular disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL064793-14
Application #
8717703
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Charette, Marc F
Project Start
2000-03-07
Project End
2017-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
14
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
New Haven
State
CT
Country
United States
Zip Code
06510
Park, Eon Joo; Grabińska, Kariona A; Guan, Ziqiang et al. (2016) NgBR is essential for endothelial cell glycosylation and vascular development. EMBO Rep 17:167-77
Marin, Ethan P; Jozsef, Levente; Di Lorenzo, Annarita et al. (2016) The Protein Acyl Transferase ZDHHC21 Modulates α1 Adrenergic Receptor Function and Regulates Hemodynamics. Arterioscler Thromb Vasc Biol 36:370-9
Grabińska, Kariona A; Park, Eon Joo; Sessa, William C (2016) cis-Prenyltransferase: New Insights into Protein Glycosylation, Rubber Synthesis, and Human Diseases. J Biol Chem 291:18582-90
Kraehling, Jan R; Hao, Zhengrong; Lee, Monica Y et al. (2016) Uncoupling Caveolae From Intracellular Signaling In Vivo. Circ Res 118:48-55
Ulrich, Victoria; Rotllan, Noemi; Araldi, Elisa et al. (2016) Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice. EMBO Mol Med 8:643-53
Landskroner-Eiger, Shira; Qiu, Cong; Perrotta, Paola et al. (2015) Endothelial miR-17∼92 cluster negatively regulates arteriogenesis via miRNA-19 repression of WNT signaling. Proc Natl Acad Sci U S A 112:12812-7
Xie, Yi; Jin, Yu; Merenick, Bethany L et al. (2015) Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition. Sci Signal 8:ra44
Rotllan, Noemi; Chamorro-Jorganes, Aránzazu; Araldi, Elisa et al. (2015) Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis. FASEB J 29:597-610
Siragusa, Mauro; Fröhlich, Florian; Park, Eon Joo et al. (2015) Stromal cell-derived factor 2 is critical for Hsp90-dependent eNOS activation. Sci Signal 8:ra81
Goodwin, Julie E; Zhang, Xinbo; Rotllan, Noemi et al. (2015) Endothelial glucocorticoid receptor suppresses atherogenesis--brief report. Arterioscler Thromb Vasc Biol 35:779-82

Showing the most recent 10 out of 99 publications